Overview

A number of stimulating new advances in the renin angiotensin field highlight the myriad roles of this important hormonal system in disease. The recent discovery of the renin receptor and the growing importance of ACE2 add new excitement to the field. In addition, new clinical trials and animal studies clearly link the renin angiotensin system to the progression of diabetes, cancer, cardiovascular and renal disease. The planned sessions in this conference maintain our tradition of exploring advances in molecular mechanisms, translational studies in animals, and application to human disease. This meeting affords an opportunity to interact with international leaders in angiotensin research and to discover the most exciting new advances in all aspects of the renin angiotensin system. In past meetings, discussion has been lively as researchers exchange their diverse perspectives on new advances.

Meeting Participation

Participation from meeting applicants is encouraged through a young investigators session, the selection of many short talks from the submitted abstracts, and evening poster sessions. If you are interested in being considered for the young investigators session, please indicate your interest in the "activities" field of the application form. Young investigators are considered to be graduate students, post-doctoral fellows, and Instructors or Assistant Professors in the first 2 years of their faculty appointments.

Steering Committee

Kenneth M. Baker, Kenneth Bernstein, Kathy Griendling, László Hunyady, Genevieve Nguyen, Martin Paul, Kathryn Sandberg, Curt D. Sigmund, Walter Thomas